Qin, Xiaohang
Wang, Cong
Gong, Guanzhong
Wang, Lizhen
Su, Ya
Yin, Yong
Article History
Received: 1 August 2022
Accepted: 31 October 2022
First Online: 8 November 2022
Declarations
:
: The Ethics Committee (IRB) at Shandong Cancer Hospital and Institute reviewed and discussed the protocol and other aspects of this research. After a vote (Total 11, Agree 11, Disagree 0), the IRB agreed that the study followed the guidelines of good clinical practice (GCP) and that the trial could be conducted at Shandong Cancer Hospital and Institute. The ethics committee of Shandong Cancer Hospital and Institute that approved the study ruled that no formal consent was necessary. Because this study was a retrospective study, all patients received normal treatment in the hospital, the study did not have any impact on the subjects, and the final data were anonymized. All methods of this study were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no conflicts of interest.